Compare GECC & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GECC | LONA |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | 26 |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.8M | 83.7M |
| IPO Year | N/A | N/A |
| Metric | GECC | LONA |
|---|---|---|
| Price | $5.55 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $10.75 | $10.00 |
| AVG Volume (30 Days) | ★ 57.3K | 33.8K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 21.62% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.92 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.63 | $4.21 |
| 52 Week High | $11.45 | $14.21 |
| Indicator | GECC | LONA |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 46.73 |
| Support Level | $4.85 | $8.00 |
| Resistance Level | $7.07 | $12.47 |
| Average True Range (ATR) | 0.19 | 1.09 |
| MACD | 0.08 | -0.25 |
| Stochastic Oscillator | 78.26 | 20.12 |
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).